Institutions / KVP Capital Advisors, LP
KVP Capital Advisors, LP
CIK 1858198 · Institution · as of Dec 31, 2025
Portfolio value
$96.82M
Positions
25
As of
Dec 31, 2025
Top holdings
Dec 31, 2025
| Company | Value | % of portfolio |
|---|---|---|
| Terns Pharmaceuticals, Inc. | $17.78M | 18.4% |
| Praxis Precision Medicines, Inc. | $12.64M | 13.1% |
| Axsome Therapeutics, Inc. | $6.61M | 6.8% |
| Whitehawk Therapeutics, Inc.WHWK | $5.24M | 5.4% |
| Trevi Therapeutics, Inc. | $5.18M | 5.4% |
| Insmed Inc | $4.96M | 5.1% |
| Protagonist Therapeutics Inc | $4.63M | 4.8% |
| Disc Medicine, Inc.IRON | $4.63M | 4.8% |
| MBX Biosciences, Inc.MBX | $3.83M | 4.0% |
| Savara IncSVRA | $3.65M | 3.8% |
| Travere Therapeutics, Inc. | $3.48M | 3.6% |
| Edgewise Therapeutics, Inc. | $3.30M | 3.4% |
| Jazz Pharmaceuticals PLC | $2.98M | 3.1% |
| Soleno Therapeutics, Inc. | $2.76M | 2.9% |
| United Therapeutics Corp | $2.31M | 2.4% |
| Achieve Life Sciences, Inc.ACHV | $2.30M | 2.4% |
| Revolution Medicines, Inc. | $2.19M | 2.3% |
| Scholar Rock Holding Corp | $1.98M | 2.0% |
| Vera Therapeutics, Inc. | $1.66M | 1.7% |
| Immix Biopharma, Inc. | $1.21M | 1.2% |
| Nektar Therapeutics | $1.14M | 1.2% |
| Cabaletta Bio, Inc. | $1.11M | 1.1% |
| Fulcrum Therapeutics, Inc. | $565.5K | 0.6% |
| Celcuity Inc.CELC | $399.0K | 0.4% |
| Vyne Therapeutics Inc | $290.4K | 0.3% |
Activity
Dec 31, 2025
InsidersInstitutions
This fund's 13F position changes — what it's buying and selling.No quarter-over-quarter changes yet — position changes appear once we've ingested two consecutive 13F filings for this manager. We currently hold 1 quarter of holdings.